We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,335.00 | 1,333.50 | 1,334.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.23 | 55.34B |
Date | Subject | Author | Discuss |
---|---|---|---|
20/5/2021 23:13 | To Brian 3777 Lucozade and Ribena were great brands in the GSK portfolio but for years the company was berated for low margins and as Lucozade and Ribena were increasingly successful their effect to dilute group margin was increasingly negative, they had a gross Margin of about 40% which was considerably below pharma. Their sales were about £ 500m p/a. It was much the same story with Horlicks which was about the same size. A great product particularly in India where the majority of sales were. And frankly Suntory and Unilever saw them as potential jewels in their crown because they operate in those businesses, and have invested time and energy and are doing a good job with them too. Horlicks has #1 or #2 brand recognition in India and needed a lot of big investment. A good time to sell. That they were income generators is true and an example of that is in the days of Beecham Lucozade was seen as "liquid Gold" and in fact one year funded the major investment for Augmentin in the 1980's! there was also the point at which it was sold that Lucozade was seen as a high sugar drink ( High energy) so one could argue that GSK sold at a good time. | hamilton23 | |
20/5/2021 18:07 | Yes I agree GSK balanced the ex-div 19p drop by tracking the rise in the Ftse . | abdullla | |
20/5/2021 17:55 | If ex dividend had happened to be Wednesday when the ftse dropped, GSK probably would have lost about 12p (or 31p in total) | bull19 | |
20/5/2021 17:49 | All other things being equal, share price will always drop by the dividend amount on ex dividend. The reason it doesn't actaully result in an exact decrease of that amount is because there are always other factors affecting share price. The fact that GSK notionally increased by 12.2p has nothing to do with the dividend. The FTSE100 increased 1% today and the 12.2p "increase" in GSK is in line with that. | bull19 | |
20/5/2021 17:04 | That's why I bought another 14,000 shares on Tuesday. | patientcapital | |
20/5/2021 16:27 | Being Clever after the event,as they say hindsight is a wonderful thing and as such self praise is no praise at all ! | abdullla | |
20/5/2021 15:40 | I hope you doomsters learnt something today, shareprice does not always fall has much has the dividend paid. GSK up 12.2p on the day. Has predicted by the No.1 trader. | montyhedge | |
20/5/2021 15:20 | GlaxoSmithKline has sold its entire stake in Innoviva back to the U.S.-based biopharmaceutical company for about $392 million, the British drugmaker said on Thursday, as it simplifies operations ahead of a split into two businesses. The London-listed company said it sold roughly 32 million shares in the Nasdaq-listed Innoviva for $12.25 per share, a marginal discount to the stock's closing price of $12.29 on Wednesday. GSK will give details in June on its plan to separate next year into an over-the-counter products business and another for prescription drugs and vaccines. Preparations have hurt earnings, but the company hopes the streamlining will pay off in the long term. Shares of GSK were 0.3% lower at 1,361.3 pence by 1427 GMT, while Innoviva gained 5.1% to about $13. An existing collaboration between the companies on respiratory treatments is not affected by the share sale, GSK said, adding the disposal frees up capital to help make more investments in line with its strategic priorities. Under the respiratory deal, GSK pays royalties to Innoviva on lung drugs Trelegy Ellipta, Relvar/Breo Ellipta and Anoro Ellipta that the companies co-developed. | tradermichael | |
20/5/2021 13:16 | I couldn't work out the last comment either, TraderMichael? Good luck everyone, Sid. | eaaxs06 | |
20/5/2021 13:13 | Well at least Elliott hedgie got the 19p on a couple of billions pounds worth of shares, I would not say no to that, lol. | montyhedge | |
20/5/2021 10:48 | Please explain? | tradermichael | |
20/5/2021 10:25 | Great predictions all. Lose 164 points for a 19p div LMAO | prokartace | |
20/5/2021 09:00 | Looking bad,SP closing more than 20p down,could be worse if the Ftse does not recover. | abdullla | |
20/5/2021 07:25 | A lot better than your guess for yesterday when you stated it would be up - 100% guarenteed! Your medical condition of selective amnesia helped you out on that one, as you conveniently forgot to mention again. Have a great day, good luck on the golf course, don't forget your clubs. Good luck everyone, Sid. | eaaxs06 | |
20/5/2021 07:06 | Predictive a 12p fall, not a bad guess down 11p. 19p tax free in the Isa bag. | montyhedge | |
19/5/2021 19:15 | Will always be marked down but not necessarily end up down by the same amount. spud | spud | |
19/5/2021 17:46 | Using montys example, if the shares close down only 12p tomorrow, that will represent a gain of 7p on the day. That was my point. Shares on ex day will always be marked down the total value of the divi plus or minus the movement on the day. | mcflies | |
19/5/2021 17:35 | Mcflies, I think on Montys comment Norm the share price falls after ex div, I thought about selling myself today but as I was just in the blue will hold on for better time in the future when all the politics is over. At least a div justifies my logic :) for now at least. GLA | charlie9038 | |
19/5/2021 16:02 | Lol you been a free member for 21 years, you still can't afford premium service and 4 followers. Bet you had a few losers. | montyhedge | |
19/5/2021 15:58 | Chances are it will be 19p or more. So those who sold today will not lose on the drop. I hope you are right, but your logic is flawed. lets see what happens tomorrow. | mcflies | |
19/5/2021 15:56 | I filtered monty years ago. He actually sleeps under a hedge. Awoken by a Cuckoo yonks, ago he has been 'cuckoo' ever since. | zeppo | |
19/5/2021 15:48 | Now what will the fall be tomorrow ex div, 19p or more, or even less, I say 12p fall. | montyhedge | |
19/5/2021 15:45 | What part of if your not holding GSK tomorrow, you sold today, you're not entitled to the dividend.You asked the question. | montyhedge | |
19/5/2021 15:41 | monty hmm.. I'm beginning to wonder about your intelligence | mcflies |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions